Key Takeaways
- Strong summer quarter, broad-based growth: Revenue grew double digits, led by a 41.8% surge in Personal Care and 15% in Food & Nutrition, as harsh summers and rural demand recovery boosted seasonal brands.
- Gross margin expansion funds brand reinvestment: Gross margin rose 314 bps YoY, but a 19.1% jump in ad spend and a one-off employee cost spike from a PF transition kept operating leverage in check.
- Balance sheet deleveraged, debt fully repaid: The company used cash flow to clear all debt, positioning for a debt-free future unless an acquisition opportunity arises.
- Strategy consultant engaged on performance-linked terms: A multi-year engagement to co-create long-term growth plans added to other expenses, with costs tied to business outcomes rather than a fixed run rate.
- What to watch next quarter: Whether the double-digit revenue growth trajectory holds in seasonally weaker Q2/Q3, the pace of margin expansion toward the 17-18% target, and the uptake of 4 upcoming product launches.
Demand & Category Performance
- Summer portfolio delivered outsized gains: Glucon-D, Nycil, and Everyuth all rode favourable weather and sustained marketing; Glucon-D benefited from micro-marketing in strategic states and 4 new digital films, while Nycil gained household penetration.
- Rural demand narrowed the gap: Rural outpaced urban, helped by a good monsoon and better-controlled inflation, though Zydus's rural mix remains a little below typical industry averages.
- Complan showing category revival: A 360-degree campaign featuring Madhuri and Sneha, plus the launch of Complan Immuno-Gro in select states, supported a turnaround in the health drink category.
- Sweeteners held dominant position: Sugar Free Green grew strong double digits on volume uptake; Sugar Free Gold was upgraded to Gold Plus with a Sucralose + Chromium formulation, removing aspartame.
- Nutralite volume grew but value lagged: Single-digit volume growth was offset by market-driven price declines, largely a food-service phenomenon; awareness campaigns and summer digital activity provided support.
- E-commerce and quick commerce are tailwinds: Online channels are growing much faster than offline, with market shares on e-commerce platforms ahead of general trade; quick commerce fits Zydus's essential-use product profile well.
- Consumer sentiment improving, cautiously: Management believes they are better placed than earlier quarters, with consumption looking more positive, but will have to see how it plays out over the next 2-3 quarters.
Arora: "over any 3- to 4-year period of time, we do expect a consistent -- sorry, double-digit growth across the portfolio. Now if a bad season happens like last year, that can happen, but that doesn't put us out too substantially"
Margins & Cost Structure
- Gross margin expanded sharply: Up 114 bps QoQ and 314 bps YoY, driven by a strong product portfolio, favourable mix, calibrated price increases taken earlier, and a hedging strategy that kept commodity costs in check.
- A&P spend rose to build brands: Advertising and promotion grew 19.1% YoY on a lower base of brand investment last year, absorbing a portion of the gross margin gain.
- Employee cost spiked on a one-off: A 25% increase came from a ~1.5% occupancy rise and a transition from a private PF to a government-based PF; management called the number "abnormally high" and said it should not be annualized.
- Other expenses inflated by consultant cost: A 27.7% YoY rise was driven by the strategy consultant engagement; excluding that, other expenses grew only 6%. The consultant cost is performance-linked, not a fixed run rate.
- Seasonal margin pattern is structural: Q2 and Q3 are smaller revenue quarters (roughly one-third of annual revenue), so fixed-cost deleverage will make EBITDA and operating margins "much lower" than Q1 and Q4. At an annualized level, the margin improvement trend is expected to be secular.
- Hedging is short-term and defensive: The company does not take long-term hedges, only low-to-medium risk positions with a 2-3 month line of sight; the overall direction of commodities has been helpful, and smarter buying has contributed.
Parikh: "This is an abnormally high number and we should not evaluate bridges."
Innovation & Portfolio Development
- Seven new products launched in Q1: Complan Immuno-Gro entered the immunity space in select states; Everyuth added pink clay and charcoal-infused anti-pollution face wash, scrub, and face pack; Nutralite launched professional mayonnaise with a Tandoori range and retail mayonnaise with carrot and cucumber sandwich spread; Nycil soap debuted internationally with 4 variants.
- Four more innovations planned: Additional launches are slated for the coming quarters, though they typically start small in limited channels and geographies before piloting and scaling.
- Sugar Free Gold reformulated: The upgrade to Gold Plus removed aspartame and added Chromium alongside Sucralose, responding to evolving consumer preferences.
- I'mlite launched with a unique proposition: A sugar blended with Stevia delivering 50% fewer calories gained positive response immediately after launch.
- Off-season portfolio building is slow: Products like Everyuth body lotion have been launched with a bias toward Q2/Q3, but they remain very small; building off-season business takes a longer period of time.
- Nycil talc category has a functional moat: While sensorial talcs have lost consumers to deodorants and sprays over time, functional talcs for prickly heat and cooling have been more consistent; management sees enough opportunity to build on this over the next 3-5 years.
Strategy & Capital Allocation
- Debt fully repaid: The company deleveraged its balance sheet during the quarter and aims to remain debt-free unless an acquisition opportunity arises.
- Capex is modest: ₹30-35 crore planned for FY25, covering maintenance and some capacity expansion equipment; no large capex is envisaged, and it will be funded through current cash flow.
- Strategy consultant engaged for long-term growth: A performance-linked engagement has been put in place to co-create strategy across the PAN business (domestic and international), with a smaller fixed element and a larger outcome-linked component tied to sales and bottom-line metrics.
- Hub-and-spoke supply chain model implemented: A recent initiative to strengthen supply chain capabilities by reorganizing supplier relationships.
- No cash tax outflow for two years: No cash tax payment is expected in FY25 and FY26 due to accumulated losses; thereafter, the company will move to the new tax regime at 25% plus.
- Pricing power intact, inflation manageable: Management states they are leaders across categories with pricing power; with extreme high inflation now out of the way, they are well-equipped to manage pricing and pass it through to consumers.
Arora: "We've got a strategy consultant who can work co-create with us to build strength because we believe we are on the right path. We are focusing on the brand building, category building. But given the task we have... we are market leaders in 5 of our brands, which means that we are not just fighting for market share, but category building."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | Double-digit growth trajectory | FY25 and going forward |
| EBITDA margin | 17-18% | Over the next couple of years (2-3 years) |
| Sweetener growth | Double-digit growth trajectory | Over the next year |
| Capex | ₹30-35 crore, maintenance and some capacity expansion | FY25 |
| Debt | Remain debt-free | Ongoing, unless acquisition opportunity arises |
| Tax cash outflow | Zero cash tax payment | FY25 and FY26 |
| New product launches | 4 more innovations | Coming quarters |
| Margin seasonality | Q2 and Q3 EBITDA/operating margins "much lower" than Q1/Q4 | Structural, every year |
Key Metrics
| Metric | Q1 FY25 |
|---|---|
| Consolidated net sales | ₹839.1 cr, +20% YoY, of which 17.1% is volume growth |
| Personal Care segment growth | 41.8% YoY |
| Food & Nutrition segment growth | 15% YoY |
| Gross margin improvement | 314 bps YoY and 114 bps QoQ |
| EBITDA | ₹155.3 cr, +33.3% YoY |
| EBITDA margin | ~18% for Q1 |
| Net profit after tax | ₹147.7 cr, +33.8% YoY |
| Adjusted PAT growth | 39.6% YoY, excluding exceptional items and one-time deferred tax effects from comparable quarter of previous year |
| Advertisement expenses growth | 19.1% YoY |
| Other expenses growth | 27.7% YoY; excluding strategy consultant cost, grew 6% |
| Employee cost increase | 25% YoY, abnormally high due to ~1.5% occupancy rise and one-off PF transition to government PF |
| Strategy consultant cost | ~₹20-21 cr, ~2.5% of quarter sales (per an analyst's math) |
| Capex planned for FY25 | ₹30-35 cr, maintenance capex |
| E-commerce share of business | ~9.5% of overall |
| Glucon-D value market share | 59.7% in glucose powder category at MAT level |
| Everyuth scrub market share | 46.2% in facial scrub category, +373 bps YoY at MAT level |
| Everyuth peel-off market share | 78.2% in peel-off category, +200 bps YoY at MAT level |
| Nycil market share | 34.9% in prickly heat powder category at MAT level |
| Sugar Free market share | 95.9% in sugar substitute category at MAT level |
| Complan market share | 4.3% in nutrition drink category at MT level |
| Glucon-D brand penetration increase | 160 bps vs last year, per MAT-May 24 Kantar Panel |
| Complan brand penetration increase | 23 bps vs last year, per MAT-May 24 Kantar Panel |
| Rural contribution to consumption | 20-30% across most brands; Glucon-D and Nycil >30%, Complan, Sugar Free, Everyuth 18-25%, Nutralite much lower |
| Distribution outlets | ~0.29-0.3 cr outlets, split 50-50 urban and rural |
| Q2 and Q3 revenue contribution | Typically ~1/3 of annual revenue |
| Medium-term EBITDA margin target | 17-18%, expected over the next couple of years |